TMR & RPNI: The Alphabet Soup in the Management of Neuromas and Neuropathic Pain
-
September 13, 2024
September 13, 2024
Most patients were treated and released, with the oropharynx the most common injury site
April 10, 2026
Sequential, multiple-assignment randomized trial compares stage I and stage II nonpharmacologic treatments over 52 weeks.
April 29, 2026
Researchers find effects vary by timing, comparator, and outcome across musculoskeletal disorders
April 7, 2026